Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s stock price was down 3.8% during trading on Wednesday . The stock traded as low as GBX 1.66 ($0.02) and last traded at GBX 1.66 ($0.02). Approximately 1,220,031 shares changed hands during trading, a decline of 35% from the average daily volume of 1,868,153 shares. The stock had previously closed at GBX 1.73 ($0.02).
Cizzle Biotechnology Trading Down 0.1 %
The stock has a market capitalization of £6.53 million, a P/E ratio of -164.80 and a beta of 0.38. The business’s fifty day simple moving average is GBX 1.79 and its two-hundred day simple moving average is GBX 1.85.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Further Reading
- Five stocks we like better than Cizzle Biotechnology
- What Investors Need to Know to Beat the Market
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
